Identification of regulators of the early stage of viral hemorrhagic septicemia virus infection during curcumin treatment

• Published in: Fish & shellfish immunology Vol. 45; no. 1; pp. 184 - 193
• Main Authors: Jeong, Eun-Hye, Vaidya, Bipin, Cho, Se-Young, Park, Myoung-Ae, Kaewintajuk, Kusuma, Kim, Seok Ryel, Oh, Myung-Joo, Choi, Jong-Soon, Kwon, Joseph, Kim, Duwoon
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.07.2015
• Subjects: Animals; Antiviral Agents - administration & dosage; Antiviral Agents - pharmacology; Curcumin; Curcumin - administration & dosage; Curcumin - pharmacology; Cyprinidae; Fish Diseases - virology; Freshwater; Gene Expression - drug effects; Heat shock cognate 71; Hemorrhagic Septicemia, Viral - virology; Novirhabdovirus - drug effects; Novirhabdovirus - physiology; Rhabdoviridae; Viral hemorrhagic septicemia virus; Viral Proteins - genetics; Viral Proteins - metabolism; Virus Replication - drug effects; Curcumin; Viral hemorrhagic septicemia virus; Heat shock cognate 71
• ISSN: 1050-4648; 1095-9947
• DOI: 10.1016/j.fsi.2015.03.042

The effect of curcumin pretreatment (15–240 μM) in fathead minnow cells infected with viral hemorrhagic septicemia virus (VHSV) was evaluated. Cell viability, apoptosis and viral copy number were analyzed using Cell Counting Kit-8 assay, Annexin V staining, and reverse transcription-PCR, respectively. Pretreatment with 120 μM curcumin showed an increase in viability (>90% of mock) of VHSV-infected cells and reduction in the copy number (0.2-log reduction in VHSV N gene expression), reactive oxygen species and apoptosis in the cells without cytotoxic effects. To understand the mechanisms underlaying the antiviral effects of curcumin pretreatment, a comparative proteomic analysis was performed in four samples (M, mock; C, curcumin-treated; V, VHSV-infected; and CV, curcumin-treated VHSV-infected) in triplicate. In total, 185 proteins were detected. The analysis showed that three proteins, including heat shock cognate 71 (HSC71), actin, alpha cardiac muscle (ACTC1) and elongation factor 1 (EEF1) were differentially expressed between V and CV samples. Network analysis performed by Ingenuity Pathways Analysis (IPA) showed that HSC71 was the primary protein interacting with fibronectin (FN) 1, actins (ACTB, ACTG, F-actin) and gelsolin (GSN) in both V and CV samples and thus is a strong target candidate for the protection from VHSV infection at the viral entry stage. Our proteomics data suggest that curcumin pretreatment inhibits entry of VHSV in cells by downregulating FN1 or upregulating F-actin. For both proteins, HSC71 acts as a binding protein that modulates their functions. Furthermore, consistent with the effect of a heat shock protein inhibitor (KNK437), curcumin downregulated HSC71 expression with increasing viability of VHSV-infected cells and inhibited VHSV replication, suggesting that the downregulation of HSC71 could be responsible for the antiviral activity of curcumin. In conclusion, this study indicates that the suppression of viral entry by rearrangement of the F-actin/G-actin ratio via downregulating HSC71 is a plausible mechanism by which curcumin pretreatment controls the early stages of VHSV infection. •Curcumin reduces early stage of viral hemorrhagic septicemia virus (VHSV) infection.•Curcumin pretreatment reduces viral copy number and reactive oxygen species.•Curcumin protects cells by downregulating fibronectin and upregulating F-actin.•Curcumin diminishes HSC71 expression.